Merck Loses Fed. Circ. Bid To Enforce Nasonex Patent
Law360 (February 9, 2018, 7:27 PM EST) — A Delaware federal judge rightly found that Amneal Pharmaceuticals LLC wouldn’t infringe one of Merck & Co. Inc.’s patents when selling a generic version of the nasal spray Nasonex, despite discovery flubs by Amneal, the Federal Circuit said Friday.